Erythropoietin, the protein that drives red blood cell formation, also induces tolerance in dendritic cells, leading to the ...
A single signaling pathway controls whether immune cells attack or befriend cells they encounter while patrolling our bodies, ...
Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...
Targeting receptors for erythropoietin on dendritic cells may be a viable strategy for treating MS and other diseases, ...
Hosted on MSN
Discovery of metabolic link to immune protein suppression offers new therapeutic avenues
The research paper, "Metabolic deficiencies underlie reduced plasmacytoid dendritic cell IFN-1 production following viral infection," was published on Feb. 7, 2025, in Nature Communications. Follow-up ...
The human small intestine absorbs nutrients while protecting us from potentially harmful microbes. One of the cell types that ...
By manipulating this pathway, scientists may be able to tweak the immune response to treat cancers, autoimmune disorders, and more.
Immunotherapy uses a person's own immune system to fight cancer. Immune checkpoint inhibitors are one class of immunotherapy that block specific proteins from slowing the immune response. As a result, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback